Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Espinel-Ingroff

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Infectious Disease Clinics of North America|January 9, 1998
Clinical relevance of antifungal resistanceA Espinel-Ingroff
Journal of Clinical Microbiology|September 1, 2006
Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin BA Espinel-Ingroff
Contributions to Microbiology|October 16, 1999
Problems of antifungal in vitro testing in Aspergillus fumigatusA Espinel-Ingroff
Diagnostic Microbiology and Infectious Disease|August 1, 1994
Etest for antifungal susceptibility testing of yeastsA Espinel-Ingroff
Journal of Clinical Microbiology|September 17, 1998
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeastsA Espinel-Ingroff
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|August 3, 2000
Clinical utility of in vitro antifungal susceptibility testingA Espinel-Ingroff
Journal of Clinical Microbiology|March 7, 2001
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungiA Espinel-Ingroff
Journal of Clinical Microbiology|February 12, 1998
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogensA Espinel-Ingroff
Antimicrobial Agents and Chemotherapy|February 13, 2001
Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazoleA Espinel-Ingroff
Journal of Clinical Microbiology|April 3, 2001
Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungiA Espinel-Ingroff
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Infectious Disease Clinics of North America|January 9, 1998
Clinical relevance of antifungal resistanceA Espinel-Ingroff
Journal of Clinical Microbiology|September 1, 2006
Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin BA Espinel-Ingroff
Contributions to Microbiology|October 16, 1999
Problems of antifungal in vitro testing in Aspergillus fumigatusA Espinel-Ingroff
Diagnostic Microbiology and Infectious Disease|August 1, 1994
Etest for antifungal susceptibility testing of yeastsA Espinel-Ingroff
Journal of Clinical Microbiology|September 17, 1998
Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeastsA Espinel-Ingroff
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|August 3, 2000
Clinical utility of in vitro antifungal susceptibility testingA Espinel-Ingroff
Journal of Clinical Microbiology|March 7, 2001
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungiA Espinel-Ingroff
Journal of Clinical Microbiology|February 12, 1998
In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogensA Espinel-Ingroff
Antimicrobial Agents and Chemotherapy|February 13, 2001
Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazoleA Espinel-Ingroff
Journal of Clinical Microbiology|April 3, 2001
Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungiA Espinel-Ingroff
Pageof 13